




Searching News Database: inhalation
HSMN NewsFeed - 3 Feb 2022
Third Pole Therapeutics Closes $25M Financing - eNOfit(TM) Wearable Device Now Ready for Clinical Trials
Third Pole Therapeutics Closes $25M Financing - eNOfit(TM) Wearable Device Now Ready for Clinical Trials
HSMN NewsFeed - 15 Sep 2021
Theravance Biopharma, Inc. Announces Strategic Actions to Focus on Respiratory Disease Portfolio
Theravance Biopharma, Inc. Announces Strategic Actions to Focus on Respiratory Disease Portfolio
HSMN NewsFeed - 13 May 2021
MindMed Bolsters Management Team, Appoints Peter Mack PhD as Vice President of Pharmaceutical Development
MindMed Bolsters Management Team, Appoints Peter Mack PhD as Vice President of Pharmaceutical Development
HSMN NewsFeed - 22 Dec 2020
Nephron Announces FDA Approval of Ketorolac, Signaling New Phase of Growth
Nephron Announces FDA Approval of Ketorolac, Signaling New Phase of Growth
HSMN NewsFeed - 17 Aug 2020
Lannett Signs Agreement To Be Exclusive Distributor Of Generic Flovent(R) Diskus(R)
Lannett Signs Agreement To Be Exclusive Distributor Of Generic Flovent(R) Diskus(R)
HSMN NewsFeed - 2 Jan 2020
CF PharmTech Closes US$ 90 Million Financing Round to Accelerate Global Development of Respiratory Drugs
CF PharmTech Closes US$ 90 Million Financing Round to Accelerate Global Development of Respiratory Drugs
HSMN NewsFeed - 21 Dec 2018
Mallinckrodt And NPXe Announce First Patient Enrolled In Phase 3 Trial Of Inhaled Xenon Gas Therapy
Mallinckrodt And NPXe Announce First Patient Enrolled In Phase 3 Trial Of Inhaled Xenon Gas Therapy
HSMN NewsFeed - 4 Sep 2018
United Therapeutics And MannKind Announce Collaboration For Pulmonary Hypertension Products
United Therapeutics And MannKind Announce Collaboration For Pulmonary Hypertension Products
HSMN NewsFeed - 23 Aug 2018
Mallinckrodt And NPXe Announce FDA Fast Track Designation For Phase 3 Trial Of Inhaled Xenon Gas Therapy
Mallinckrodt And NPXe Announce FDA Fast Track Designation For Phase 3 Trial Of Inhaled Xenon Gas Therapy
HSMN NewsFeed - 8 May 2018
TFF Pharmaceuticals Announces Appointment of Glenn Mattes as New Chief Executive Officer
TFF Pharmaceuticals Announces Appointment of Glenn Mattes as New Chief Executive Officer
HSMN NewsFeed - 20 Apr 2018
UCB to Expand Epilepsy Portfolio With Strategic Acquisition of Midazolam Nasal Spray From Proximagen
UCB to Expand Epilepsy Portfolio With Strategic Acquisition of Midazolam Nasal Spray From Proximagen
HSMN NewsFeed - 3 Apr 2018
Biopharm Startup TFF Pharmaceuticals Raises $14M for Breakthrough Dry Powder Inhalation Platform
Biopharm Startup TFF Pharmaceuticals Raises $14M for Breakthrough Dry Powder Inhalation Platform
HSMN NewsFeed - 23 Oct 2017
United Therapeutics Announces FDA Approval of Third Generation Nebulizer for the Tyvaso(R) Inhalation System
United Therapeutics Announces FDA Approval of Third Generation Nebulizer for the Tyvaso(R) Inhalation System
HSMN NewsFeed - 20 Mar 2017
Piramal Pharma Solutions Names Stuart E. Needleman as Chief Commercial Officer
Piramal Pharma Solutions Names Stuart E. Needleman as Chief Commercial Officer
HSMN NewsFeed - 27 Dec 2016
Amphastar Pharmaceuticals Receives Complete Response Letter for Primatene(R) Mist
Amphastar Pharmaceuticals Receives Complete Response Letter for Primatene(R) Mist
HSMN NewsFeed - 5 Oct 2016
Insmed Announces Worldwide License Agreement with AstraZeneca for Oral DPP1 Inhibitor
Insmed Announces Worldwide License Agreement with AstraZeneca for Oral DPP1 Inhibitor
HSMN NewsFeed - 14 Jun 2016
Nephron Pharmaceuticals Corporation Launches Generic Budesonide Inhalation Suspension
Nephron Pharmaceuticals Corporation Launches Generic Budesonide Inhalation Suspension
HSMN NewsFeed - 24 Feb 2016
Alexza Pharmaceuticals Reacquires U.S. Commercial Rights for ADASUVE(R) (loxapine) inhalation powder
Alexza Pharmaceuticals Reacquires U.S. Commercial Rights for ADASUVE(R) (loxapine) inhalation powder
HSMN NewsFeed - 25 Jan 2016
Piramal Critical Care and Cumberland Pharmaceuticals Announce Launch of Caldolor and Vaprisol Co-Promotion
Piramal Critical Care and Cumberland Pharmaceuticals Announce Launch of Caldolor and Vaprisol Co-Promotion
HSMN NewsFeed - 1 Jul 2014
Paratek Appoints Michael Bigham as Chairman and CEO and Promotes Evan Loh to President and CMO
Paratek Appoints Michael Bigham as Chairman and CEO and Promotes Evan Loh to President and CMO
HSMN NewsFeed - 29 Apr 2014
Teva Receives European Marketing Authorization for DuoResp Spiromax(R) for the Treatment of Asthma and COPD
Teva Receives European Marketing Authorization for DuoResp Spiromax(R) for the Treatment of Asthma and COPD
HSMN NewsFeed - 27 Mar 2014
Baxter Announces Plans to Create Two Separate Leading Global Healthcare Companies
Baxter Announces Plans to Create Two Separate Leading Global Healthcare Companies
HSMN NewsFeed - 10 Feb 2014
Mast Therapeutics Signs Definitive Agreement To Acquire Aires Pharmaceuticals, Inc.
Mast Therapeutics Signs Definitive Agreement To Acquire Aires Pharmaceuticals, Inc.
HSMN NewsFeed - 20 Sep 2013
RELVAR(TM) ELLIPTA(TM) Gains Approval in Japan for the Treatment of Asthma
RELVAR(TM) ELLIPTA(TM) Gains Approval in Japan for the Treatment of Asthma
HSMN NewsFeed - 30 Aug 2013
Acton Pharmaceuticals, Inc. to Be Acquired by Meda for Up to $200 Million
Acton Pharmaceuticals, Inc. to Be Acquired by Meda for Up to $200 Million
HSMN NewsFeed - 30 Jul 2013
Alexza Pharmaceuticals Announces European Launch of ADASUVE(R) (Staccato(R) Loxapine)
Alexza Pharmaceuticals Announces European Launch of ADASUVE(R) (Staccato(R) Loxapine)
HSMN NewsFeed - 8 May 2013
Teva and Alexza Announce Teva’s License to Market ADASUVE(R) in the U.S.
Teva and Alexza Announce Teva’s License to Market ADASUVE(R) in the U.S.
HSMN NewsFeed - 21 Feb 2013
Alexza Receives Marketing Authorization for ADASUVE(R) (Staccato(R) Loxapine) in the European Union
Alexza Receives Marketing Authorization for ADASUVE(R) (Staccato(R) Loxapine) in the European Union
HSMN NewsFeed - 7 Nov 2012
Insmed Appoints 15-Year Life Sciences Industry Veteran Andrew Drechsler as Chief Financial Officer
Insmed Appoints 15-Year Life Sciences Industry Veteran Andrew Drechsler as Chief Financial Officer
HSMN NewsFeed - 26 Oct 2012
NICE Approves Pharmaxis' Bronchitol(R) As An Important New Treatment Option For Cystic Fibrosis Patients
NICE Approves Pharmaxis' Bronchitol(R) As An Important New Treatment Option For Cystic Fibrosis Patients
HSMN NewsFeed - 28 Sep 2012
Seebri(R) Inhalation Capsules Receive MHLW Approval as Once-daily Maintenance Treatment for COPD in Japan
Seebri(R) Inhalation Capsules Receive MHLW Approval as Once-daily Maintenance Treatment for COPD in Japan
HSMN NewsFeed - 5 Sep 2012
Sunovion Pharmaceuticals Inc. Completes Acquisition of Elevation Pharmaceuticals, Inc.
Sunovion Pharmaceuticals Inc. Completes Acquisition of Elevation Pharmaceuticals, Inc.
HSMN NewsFeed - 4 Jun 2012
Hi-Tech Pharmacal Acquires Rights to the Cormax(R) Brand for its ECR Pharmaceuticals Subsidiary
Hi-Tech Pharmacal Acquires Rights to the Cormax(R) Brand for its ECR Pharmaceuticals Subsidiary
HSMN NewsFeed - 24 Feb 2012
Forest Laboratories Receives European Marketing Approval for Colobreathe(R) Dry Powder Inhaler
Forest Laboratories Receives European Marketing Approval for Colobreathe(R) Dry Powder Inhaler
HSMN NewsFeed - 18 Jan 2012
Hi-Tech Pharmacal’s ECR Pharmaceuticals Subsidiary Launches Hylase(R) Wound Gel
Hi-Tech Pharmacal’s ECR Pharmaceuticals Subsidiary Launches Hylase(R) Wound Gel
HSMN NewsFeed - 3 Oct 2011
Ventus Medical Launches Provent(R) Sleep Apnea Therapy in Australia and New Zealand
Ventus Medical Launches Provent(R) Sleep Apnea Therapy in Australia and New Zealand
HSMN NewsFeed - 28 Sep 2011
Graceway Pharmaceuticals, LLC Reaches Agreement to Sell its Assets to Galderma S.A.
Graceway Pharmaceuticals, LLC Reaches Agreement to Sell its Assets to Galderma S.A.
HSMN NewsFeed - 9 Aug 2011
MAP Pharmaceuticals Appoints Frederick H. Graff Vice President, Commercial Operations
MAP Pharmaceuticals Appoints Frederick H. Graff Vice President, Commercial Operations
HSMN NewsFeed - 20 Jun 2011
Pulmatrix Launches iSPERSE(TM), A Novel Inhaled Dry Powder Drug Delivery Platform
Pulmatrix Launches iSPERSE(TM), A Novel Inhaled Dry Powder Drug Delivery Platform
HSMN NewsFeed - 25 Mar 2011
FDA Approves Zyclara(R) (imiquimod) Cream, 3.75% for the Treatment of External Genital Warts
FDA Approves Zyclara(R) (imiquimod) Cream, 3.75% for the Treatment of External Genital Warts
HSMN NewsFeed - 18 Feb 2011
MAP Pharmaceuticals Appoints Scott R. Ward as Chairman of the Board of Directors
MAP Pharmaceuticals Appoints Scott R. Ward as Chairman of the Board of Directors
HSMN NewsFeed - 11 Jan 2011
SUMAVEL DosePro Receives Marketing Approval in Germany and the United Kingdom
SUMAVEL DosePro Receives Marketing Approval in Germany and the United Kingdom
HSMN NewsFeed - 10 Aug 2010
Advanced Life Sciences Achieves Special Protocol Assessment Agreement With FDA for Restanza in Pneumonia
Advanced Life Sciences Achieves Special Protocol Assessment Agreement With FDA for Restanza in Pneumonia
HSMN NewsFeed - 23 Jul 2010
Emisphere Provides an Update on Osteoarthritis Phase III Study With Oral Calcitonin
Emisphere Provides an Update on Osteoarthritis Phase III Study With Oral Calcitonin
HSMN NewsFeed - 22 Jul 2010
Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
HSMN NewsFeed - 11 May 2010
MAP Pharmaceuticals Provides Update on Progress of LEVADEX Development Program
MAP Pharmaceuticals Provides Update on Progress of LEVADEX Development Program
HSMN NewsFeed - 23 Apr 2010
InteKrin Therapeutics Appoints Roman Skowronski, MD, PhD as Vice President of Clinical Development
InteKrin Therapeutics Appoints Roman Skowronski, MD, PhD as Vice President of Clinical Development
HSMN NewsFeed - 26 Mar 2010
FDA Approves Zyclara(TM) (imiquimod) Cream, 3.75% for the Treatment of Actinic Keratoses
FDA Approves Zyclara(TM) (imiquimod) Cream, 3.75% for the Treatment of Actinic Keratoses
HSMN NewsFeed - 9 Mar 2010
FDA Clears GeNO LLC Investigational New Drug Application for Nitric Oxide Delivery System
FDA Clears GeNO LLC Investigational New Drug Application for Nitric Oxide Delivery System
HSMN NewsFeed - 9 Mar 2010
Human Genome Sciences Appoints David P. Southwell Executive Vice President and Chief Financial Officer
Human Genome Sciences Appoints David P. Southwell Executive Vice President and Chief Financial Officer
HSMN NewsFeed - 19 Feb 2010
Sepracor Announces New Management Changes and Plans for Merger with Dainippon Sumitomo Pharma America
Sepracor Announces New Management Changes and Plans for Merger with Dainippon Sumitomo Pharma America
HSMN NewsFeed - 16 Feb 2010
Hi-Tech Pharmacal's ECR Subsidiary to Co-Promote Unique Kidney Stone Treatment
Hi-Tech Pharmacal's ECR Subsidiary to Co-Promote Unique Kidney Stone Treatment
HSMN NewsFeed - 6 Jan 2010
Acton Pharmaceuticals, Inc. Announces Completion of $15 Million Series A Financing with Sequoia Capital
Acton Pharmaceuticals, Inc. Announces Completion of $15 Million Series A Financing with Sequoia Capital
HSMN NewsFeed - 17 Dec 2009
FDA Approves SPIRIVA(R) HandiHaler(R) for the Reduction of COPD Exacerbations
FDA Approves SPIRIVA(R) HandiHaler(R) for the Reduction of COPD Exacerbations
HSMN NewsFeed - 17 Dec 2009
Sepracor Granted Patent Term Extension for LUNESTA(R) and Provides Update on LUNESTA Pediatric Studies
Sepracor Granted Patent Term Extension for LUNESTA(R) and Provides Update on LUNESTA Pediatric Studies
HSMN NewsFeed - 16 Dec 2009
Savara Closes Second Tranche of Series A Financing Round, Receives Allowance for Base Patent
Savara Closes Second Tranche of Series A Financing Round, Receives Allowance for Base Patent
HSMN NewsFeed - 1 Dec 2009
MAP Pharmaceuticals Appoints Alan Petro Vice President, Manufacturing and Technical Operations
MAP Pharmaceuticals Appoints Alan Petro Vice President, Manufacturing and Technical Operations
HSMN NewsFeed - 9 Jul 2009
MAP Pharmaceuticals Announces Termination of Pediatric Asthma Collaboration
MAP Pharmaceuticals Announces Termination of Pediatric Asthma Collaboration
HSMN NewsFeed - 8 Jul 2009
Antares Pharma Promotes Robert F. Apple, Dr. Kaushik Dave and Dr. Peter Sadowski
Antares Pharma Promotes Robert F. Apple, Dr. Kaushik Dave and Dr. Peter Sadowski
HSMN NewsFeed - 26 May 2009
MAP Pharmaceuticals Phase 3 Trial of LEVADEX(TM) Migraine Product Candidate Meets All Four Primary Endpoints
MAP Pharmaceuticals Phase 3 Trial of LEVADEX(TM) Migraine Product Candidate Meets All Four Primary Endpoints
HSMN NewsFeed - 21 May 2009
Budesonide/Formoterol Plus Tiotropium Improves the Quality of Life of Patients With Severe COPD
Budesonide/Formoterol Plus Tiotropium Improves the Quality of Life of Patients With Severe COPD
HSMN NewsFeed - 19 May 2009
Emisphere Technologies Appoints Franklin M. Berger to Its Board of Directors
Emisphere Technologies Appoints Franklin M. Berger to Its Board of Directors
HSMN NewsFeed - 13 May 2009
Follica Appoints Drug Development and Dermatology Veteran, William D. Ju, as Chief Executive Officer
Follica Appoints Drug Development and Dermatology Veteran, William D. Ju, as Chief Executive Officer
HSMN NewsFeed - 29 Jan 2009
Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration
Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration
HSMN NewsFeed - 29 Jan 2009
Alexza Consolidates Operations to Focus Resources on AZ-004 (Staccato(R) Loxapine) for Acute Agitation
Alexza Consolidates Operations to Focus Resources on AZ-004 (Staccato(R) Loxapine) for Acute Agitation
HSMN NewsFeed - 19 Jan 2009
Environmental Tectonics Corporation Announces the Sale of Two BARA-MED(R) XD Monoplace Hyperbaric Chambers
Environmental Tectonics Corporation Announces the Sale of Two BARA-MED(R) XD Monoplace Hyperbaric Chambers
HSMN NewsFeed - 8 Jan 2009
TOPIGEN Pharmaceuticals Reports Phase 2 Results of TPI ASM8 in Asthma Patients
TOPIGEN Pharmaceuticals Reports Phase 2 Results of TPI ASM8 in Asthma Patients
HSMN NewsFeed - 6 Jan 2009
DOR BioPharma Obtains Fast Track Designation for DOR201 in the Prevention of Acute Radiation Enteritis
DOR BioPharma Obtains Fast Track Designation for DOR201 in the Prevention of Acute Radiation Enteritis
HSMN NewsFeed - 31 Dec 2008
Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million
Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million
HSMN NewsFeed - 1 Oct 2008
Advanced Life Sciences and Wyeth Sign Commercialization Agreement for Cethromycin in Asia Pacific Region
Advanced Life Sciences and Wyeth Sign Commercialization Agreement for Cethromycin in Asia Pacific Region
HSMN NewsFeed - 1 Oct 2008
Advanced Life Sciences Announces NDA Submission for Cethromycin in Community Acquired Pneumonia
Advanced Life Sciences Announces NDA Submission for Cethromycin in Community Acquired Pneumonia
HSMN NewsFeed - 24 Sep 2008
New Data Show Efficacy and Safety of Eslicarbazepine Acetate in the Treatment of Epilepsy
New Data Show Efficacy and Safety of Eslicarbazepine Acetate in the Treatment of Epilepsy
HSMN NewsFeed - 23 Sep 2008
US Court Denies Teva's Motion for Summary Judgment in PULMICORT RESPULES(R) Patent Litigation
US Court Denies Teva's Motion for Summary Judgment in PULMICORT RESPULES(R) Patent Litigation
HSMN NewsFeed - 2 Sep 2008
Ikaria(R) Acquires North American Rights to LUCASSIN(R) From Orphan Therapeutics
Ikaria(R) Acquires North American Rights to LUCASSIN(R) From Orphan Therapeutics
HSMN NewsFeed - 25 Aug 2008
Ikaria(R) Strengthens Commercial Operations and Human Resources Leadership
Ikaria(R) Strengthens Commercial Operations and Human Resources Leadership
HSMN NewsFeed - 30 Jun 2008
New Drug Application for Inhaled Treprostinil Submitted to the U.S. Food and Drug Administration
New Drug Application for Inhaled Treprostinil Submitted to the U.S. Food and Drug Administration
HSMN NewsFeed - 12 Jun 2008
Mindray's AS3000(TM) Anesthesia Delivery System Receives U.S. FDA Clearance
Mindray's AS3000(TM) Anesthesia Delivery System Receives U.S. FDA Clearance
HSMN NewsFeed - 6 Jun 2008
Inspire Announces Achievement of Primary Endpoint in Phase 3 Trial with Denufosol for Cystic Fibrosis
Inspire Announces Achievement of Primary Endpoint in Phase 3 Trial with Denufosol for Cystic Fibrosis
HSMN NewsFeed - 4 Jun 2008
AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six
AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six
HSMN NewsFeed - 3 Jun 2008
Sepracor Completes Acquisition of Oryx Pharmaceuticals and Expands Operations in Canada
Sepracor Completes Acquisition of Oryx Pharmaceuticals and Expands Operations in Canada
HSMN NewsFeed - 29 May 2008
Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations
Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations
HSMN NewsFeed - 21 May 2008
Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50
Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50
HSMN NewsFeed - 19 May 2008
Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd.
Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd.
HSMN NewsFeed - 15 May 2008
Human Genome Sciences Names Kevin P. McRaith Vice President, Hepatology Franchise
Human Genome Sciences Names Kevin P. McRaith Vice President, Hepatology Franchise
HSMN NewsFeed - 1 May 2008
Sepracor to Acquire Oryx Pharmaceuticals Inc. and Expand Commercial Operations into Canada
Sepracor to Acquire Oryx Pharmaceuticals Inc. and Expand Commercial Operations into Canada
HSMN NewsFeed - 30 Apr 2008
FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD
FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD
HSMN NewsFeed - 17 Mar 2008
NIR Diagnostics signs regional agreement with European medical device distributor for HemoNIR(TM)
NIR Diagnostics signs regional agreement with European medical device distributor for HemoNIR(TM)
HSMN NewsFeed - 27 Feb 2008
Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
HSMN NewsFeed - 25 Feb 2008
Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
HSMN NewsFeed - 21 Feb 2008
Talecris Biotherapeutics Celebrates 20th Anniversary of Launch of Prolastin(R)
Talecris Biotherapeutics Celebrates 20th Anniversary of Launch of Prolastin(R)
HSMN NewsFeed - 11 Feb 2008
Hi-Tech Pharmacal Receives Approval for Hydrocodone Bitartrate and Homatropine Methylbromide Syrup
Hi-Tech Pharmacal Receives Approval for Hydrocodone Bitartrate and Homatropine Methylbromide Syrup
HSMN NewsFeed - 22 Jan 2008
RxElite Appoints Rick Schindewolf Vice President for Business Development
RxElite Appoints Rick Schindewolf Vice President for Business Development
HSMN NewsFeed - 16 Jan 2008
Hi-Tech Pharmacal Receives Final Approval for Fluticasone Propionate Nasal Spray, 50mcg
Hi-Tech Pharmacal Receives Final Approval for Fluticasone Propionate Nasal Spray, 50mcg
HSMN NewsFeed - 16 Jan 2008
Teva Specialty Pharmaceuticals and UCB Announce U.S. Respiratory Collaboration Agreement
Teva Specialty Pharmaceuticals and UCB Announce U.S. Respiratory Collaboration Agreement
HSMN NewsFeed - 3 Jan 2008
Akela Pharma licenses Fentanyl TAIFUN(R) to Janssen Pharmaceutica NV for Canada
Akela Pharma licenses Fentanyl TAIFUN(R) to Janssen Pharmaceutica NV for Canada
HSMN NewsFeed - 27 Dec 2007
Endo Pharmaceuticals to Develop and Commercialize Alexza's AZ-003 Staccato(R) Inhaled Fentanyl Product
Endo Pharmaceuticals to Develop and Commercialize Alexza's AZ-003 Staccato(R) Inhaled Fentanyl Product
HSMN NewsFeed - 17 Dec 2007
Heyer Medical AG Launches New Anesthesia Remote Management Based on ComBrio's Virtual Service Infrastructure
Heyer Medical AG Launches New Anesthesia Remote Management Based on ComBrio's Virtual Service Infrastructure
HSMN NewsFeed - 1 Nov 2007
Triumph-1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint
Triumph-1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint
HSMN NewsFeed - 30 Oct 2007
Emphasys Medical Granted Expedited Review From FDA for Zephyr(R) Endobronchial Valve
Emphasys Medical Granted Expedited Review From FDA for Zephyr(R) Endobronchial Valve
HSMN NewsFeed - 24 Oct 2007
Emisphere Technologies, Inc. Appoints Gary Riley as Vice President Nonclinical Development & Applied Biology
Emisphere Technologies, Inc. Appoints Gary Riley as Vice President Nonclinical Development & Applied Biology
HSMN NewsFeed - 4 Oct 2007
Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
HSMN NewsFeed - 25 Sep 2007
Critical Therapeutics Highlights Near-Term Milestones to Drive Commercial Success and Clinical Development
Critical Therapeutics Highlights Near-Term Milestones to Drive Commercial Success and Clinical Development
HSMN NewsFeed - 20 Sep 2007
Robert S. Fishman, MD, FCCP Joins Alexza as Vice President, Medical Affairs
Robert S. Fishman, MD, FCCP Joins Alexza as Vice President, Medical Affairs
HSMN NewsFeed - 18 Sep 2007
New Data Support Long-Term Efficacy and Safety in Patients Who Took Exubera for Eight Years
New Data Support Long-Term Efficacy and Safety in Patients Who Took Exubera for Eight Years
HSMN NewsFeed - 23 Aug 2007
Ventaira Pharmaceuticals Appoints Lex Adjei, Ph.D. as Vice President, Research and Development
Ventaira Pharmaceuticals Appoints Lex Adjei, Ph.D. as Vice President, Research and Development
HSMN NewsFeed - 10 Aug 2007
MAP Pharmaceuticals Appoints Shashidhar Kori New Vice President of Clinical Development
MAP Pharmaceuticals Appoints Shashidhar Kori New Vice President of Clinical Development
HSMN NewsFeed - 10 Aug 2007
MAP Pharmaceuticals Promotes Stephen B. Shrewsbury to Position of Chief Medical Officer
MAP Pharmaceuticals Promotes Stephen B. Shrewsbury to Position of Chief Medical Officer
HSMN NewsFeed - 27 Jul 2007
Sepracor Submits LUNIVIA(R) (LUNESTA(R) in U.S.) Marketing Authorization Application (MAA) for Europe
Sepracor Submits LUNIVIA(R) (LUNESTA(R) in U.S.) Marketing Authorization Application (MAA) for Europe
HSMN NewsFeed - 16 Jul 2007
Barr Confirms Patent Challenge of Xopenex(R) Inhalation Solution, 0.31mg/3mL, 0.63mg/3mL and 1.25mg/3mL
Barr Confirms Patent Challenge of Xopenex(R) Inhalation Solution, 0.31mg/3mL, 0.63mg/3mL and 1.25mg/3mL
HSMN NewsFeed - 5 Jul 2007
Aradigm Corporation Names Norman Halleen as Interim Chief Financial Officer
Aradigm Corporation Names Norman Halleen as Interim Chief Financial Officer
HSMN NewsFeed - 21 Jun 2007
LAB International licenses Fentanyl TAIFUN(R) to Janssen Pharmaceutica NV for Europe
LAB International licenses Fentanyl TAIFUN(R) to Janssen Pharmaceutica NV for Europe
HSMN NewsFeed - 21 Jun 2007
Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial
Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial
HSMN NewsFeed - 5 Jun 2007
Aradigm Names D. Jeffery Grimes as General Counsel and Corporate Secretary
Aradigm Names D. Jeffery Grimes as General Counsel and Corporate Secretary
HSMN NewsFeed - 29 May 2007
Hi-Tech Pharmacal Settles Litigation with MedPointe and JFC Technologies, Acquires Vosol(R) Product Line
Hi-Tech Pharmacal Settles Litigation with MedPointe and JFC Technologies, Acquires Vosol(R) Product Line
HSMN NewsFeed - 22 May 2007
Hi-Tech Pharmacal's Founder and Chairman Emeritus, Bernard Seltzer Dies at Age 83
Hi-Tech Pharmacal's Founder and Chairman Emeritus, Bernard Seltzer Dies at Age 83
HSMN NewsFeed - 2 May 2007
MINRAD International, Inc. Announces FDA Approval of Sojourn(TM) Sevoflurane
MINRAD International, Inc. Announces FDA Approval of Sojourn(TM) Sevoflurane
HSMN NewsFeed - 1 May 2007
Solace Pharmaceuticals Raises $15M in Series A Financing; Names Senior Pfizer Executive as CEO
Solace Pharmaceuticals Raises $15M in Series A Financing; Names Senior Pfizer Executive as CEO
HSMN NewsFeed - 20 Apr 2007
Baxter Presents Phase I Inhaled Insulin Study Results at Respiratory Drug Delivery Conference
Baxter Presents Phase I Inhaled Insulin Study Results at Respiratory Drug Delivery Conference
HSMN NewsFeed - 17 Apr 2007
Hi-Tech Pharmacal Receives Tentative Approval for Ciclopirox Topical Solution
Hi-Tech Pharmacal Receives Tentative Approval for Ciclopirox Topical Solution
HSMN NewsFeed - 2 Feb 2007
Schering-Plough Cites Today's Anacor Agreement as Latest in Series of Deals
Schering-Plough Cites Today's Anacor Agreement as Latest in Series of Deals
HSMN NewsFeed - 17 Jan 2007
GlaxoSmithKline Awarded $63 Million HHS Contract for Pandemic Vaccine Research and Development
GlaxoSmithKline Awarded $63 Million HHS Contract for Pandemic Vaccine Research and Development
HSMN NewsFeed - 16 Jan 2007
Aradigm Receives FDA Orphan Drug Designation for Liposomal Ciprofloxacin for Bronchiectasis
Aradigm Receives FDA Orphan Drug Designation for Liposomal Ciprofloxacin for Bronchiectasis
HSMN NewsFeed - 3 Jan 2007
Victory Pharma, Inc. Signs NAPRELAN(R) Agreement; US Field Sales Force to Expand
Victory Pharma, Inc. Signs NAPRELAN(R) Agreement; US Field Sales Force to Expand
HSMN NewsFeed - 3 Jan 2007
Hi-Tech Pharmacal Enters into Agreement with Victory Pharma, Inc. to Market and Distribute Naprelan(R)
Hi-Tech Pharmacal Enters into Agreement with Victory Pharma, Inc. to Market and Distribute Naprelan(R)
HSMN NewsFeed - 18 Dec 2006
Aerovance Adds Accomplished Product Commercialization Executive to Leadership Team
Aerovance Adds Accomplished Product Commercialization Executive to Leadership Team
HSMN NewsFeed - 20 Nov 2006
Actelion Announces Definitive Agreement to Acquire U.S.-Based CoTherix, Inc.
Actelion Announces Definitive Agreement to Acquire U.S.-Based CoTherix, Inc.
HSMN NewsFeed - 13 Nov 2006
Approved Asthma Therapy SYMBICORT Improves Lung Function Safely and Effectively
Approved Asthma Therapy SYMBICORT Improves Lung Function Safely and Effectively
HSMN NewsFeed - 13 Nov 2006
XOPENEX HFA(R) Data Presented at American College of Allergy, Asthma and Immunology Annual Meeting
XOPENEX HFA(R) Data Presented at American College of Allergy, Asthma and Immunology Annual Meeting
HSMN NewsFeed - 9 Nov 2006
Graceway Pharmaceuticals to Acquire 3M Pharmaceuticals Business in North and Latin America
Graceway Pharmaceuticals to Acquire 3M Pharmaceuticals Business in North and Latin America
HSMN NewsFeed - 6 Nov 2006
Abbott to Expand Presence in Lipid Management Market With Acquisition of Kos Pharmaceuticals
Abbott to Expand Presence in Lipid Management Market With Acquisition of Kos Pharmaceuticals
HSMN NewsFeed - 17 Oct 2006
Detroit Receiving Offers Michigan's First Hospital-Based Hyperbaric Wound Care Program
Detroit Receiving Offers Michigan's First Hospital-Based Hyperbaric Wound Care Program
HSMN NewsFeed - 11 Oct 2006
MAP Pharmaceuticals Appoints New Sr. Vice President of Corporate and Business Development
MAP Pharmaceuticals Appoints New Sr. Vice President of Corporate and Business Development
HSMN NewsFeed - 10 Oct 2006
Hi-Tech Pharmacal Announces the Hiring of Eyal Mares as Vice President, Operations
Hi-Tech Pharmacal Announces the Hiring of Eyal Mares as Vice President, Operations
HSMN NewsFeed - 5 Oct 2006
GSK's New Flu Vaccine, FluLaval(TM), Provides Americans With a New Option for Fighting the Flu
GSK's New Flu Vaccine, FluLaval(TM), Provides Americans With a New Option for Fighting the Flu
HSMN NewsFeed - 20 Jul 2006
YM BioSciences reports anti-EGFr drug nimotuzumab approved in India for treatment of head and neck cancer
YM BioSciences reports anti-EGFr drug nimotuzumab approved in India for treatment of head and neck cancer
HSMN NewsFeed - 20 Jul 2006
GSK Announces U.S. Government Purchase of Relenza(R) for State Stockpiles
GSK Announces U.S. Government Purchase of Relenza(R) for State Stockpiles
HSMN NewsFeed - 12 Jul 2006
Kos Submits Supplemental New Drug Application To FDA For New Niaspan(R) CF Range of Products
Kos Submits Supplemental New Drug Application To FDA For New Niaspan(R) CF Range of Products
HSMN NewsFeed - 23 May 2006
Ventaira Announces Positive Scintigraphy Data with Next-Generation Pulmonary Drug Delivery Device
Ventaira Announces Positive Scintigraphy Data with Next-Generation Pulmonary Drug Delivery Device
Additional items found! 231

Members Archive contains
231 additional stories matching:
inhalation
(Password required)
inhalation
(Password required)